Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Guggenheim Downgrades Merck & Co to Neutral

Guggenheim analyst Seamus Fernandez downgrades Merck & Co (NYSE:MRK) from Buy to Neutral.

December 7, 2021

1 minute read

Guggenheim analyst Seamus Fernandez downgrades Merck & Co (NYSE:MRK) from Buy to Neutral.

Mizuho Maintains Buy on Dover, Lowers Price Target to $155

Today, 2:18 AM

Mizuho analyst Brett Linzey maintains Dover (NYSE:DOV) with a Buy and lowers the price target from $175 to $155.

Today, 2:18 AM

SVB Leerink analyst Joseph Schwartz maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and raises the price target from $182 to $190.

Today, 2:18 AM

Pactiv Evergreen (NASDAQ:PTVE) reported quarterly sales of $1.35 billion which beat the analyst consensus estimate of $1.25 billion by 8.16 percent.

Today, 2:18 AM

Telsey Advisory Group analyst Dana Telsey maintains Estee Lauder Cos (NYSE:EL) with a Outperform and raises the price target from $355 to $377.